Romidepsin: a new drug for the treatment of cutaneous T-cell lymphoma.

Clinical journal of oncology nursing

Volumn 16, Issue 2, 2012, Pages 195-204

  Frye, Robin ^a   Myers, Mary ^b   Axelrod, Karen C ^b   Ness, Elizabeth A ^b   Piekarz, Richard L ^b   Bates, Susan E ^b   Booher, Susan ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DEPSIPEPTIDE; HISTONE DEACETYLASE INHIBITOR; ROMIDEPSIN;

ANIMAL; ARTICLE; CLINICAL TRIAL (TOPIC); DRUG APPROVAL; HUMAN; NURSING; RECURRENT DISEASE; SKIN TUMOR; T CELL LYMPHOMA;

ANIMALS; ANTINEOPLASTIC AGENTS; CLINICAL TRIALS AS TOPIC; DEPSIPEPTIDES; DRUG APPROVAL; HISTONE DEACETYLASE INHIBITORS; HUMANS; LYMPHOMA, T-CELL; RECURRENCE; SKIN NEOPLASMS;

EID: 84864329991     PISSN: None     EISSN: 1538067X     Source Type: Journal    
DOI: 10.1188/12.CJON.195-204     Document Type: Article

References (0)